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Abstract
BACKGROUND
The migration rate of fully covered self-expandable metal stents (FCSEMSs) has
been reported to be between 14% to 37%. Anchoring of FCSEMSs using a doublepigtail plastic stent (DPS) may decrease migration.
AIM
To compare stent migration rates between patients who received FCSEMS alone
and those who received both an FCSEMS and anchoring DPS.
METHODS
We conducted a retrospective analysis of endoscopy reporting system and
medical records of 1366 patients who underwent endoscopic retrograde
cholangiopancreatography (ERCP) with FCSEMS placement at the University of
Kentucky health care. Between July 2015 and April 2017, 203 patients with
FCSEMS insertion for the treatment of malignant biliary stricture, benign biliary
stricture, post-sphincterotomy bleeding, bile leak, and cholangitis drainage were
identified. The review and analysis were conducted through our endoscopy
reporting system (ProVation® MD) and medical records. Categorical data were
analyzed using Chi-Square and Fischer exact test and continuous data using nonparametric tests. A regression analysis was performed to identify factors
independently associated with increased risk of stent migration. We determined
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an FCSEMS migration endoscopically if the stent was no longer visible in the
major papilla.
RESULTS
1366 patients had undergone ERCP by three advanced endoscopists over 21-mo
period; among these, 203 patients had FCSEMSs placed. 65 patients had
FCSEMSs with DPS, and 138 had FCSEMSs alone. 65 patients had FCSEMSs with
DPS, and 138 had FCSEMSs alone. 95 patients had a malignant stricture, 82
patients had a benign stricture, 12 patients had bile leak, 12 patients had
cholangitis, and nine patients had post-sphincterotomy bleeding. The migration
rate in patients with anchored FCSEMSs with DPS was 6%, and those without
anchoring DPS was 10% (P = 0.35). Overall, migration was reported in 18 patients
with FCSEMSs placement out of 203 patients with an overall migration rate of
9.7%. There was no significant association between anchoring the FCSEMSs with
DPS and the risk of stent migration. Only patients with the previous
sphincterotomy and begin biliary stricture were found to have a statistically
significant difference in the migration rate between patients who had FCSEMS
with DPS and FCSEMS alone (P = 0.01).
CONCLUSION
The risk of migration of biliary FCSEMS was 9.7 %. Anchoring an FCSEMS with
DPS does not decrease the risk of stent migration.
Key words: Metal stents; Double-pigtail plastic stent; Endoscopic retrograde
cholangiopancreatography; Biliary drainage; Biliary obstruction
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: In this study, we conducted a retrospective analysis to evaluate the efficacy of
7-French (Fr) and 10-Fr double-pigtail plastic stent (DPS) within the fully covered selfexpandable metal stent (FCSEMS) as an anti-migration technique. We compared the rate
of stent migration between patients who received FCSEMS alone and those who
received both an FCSEMS and anchoring DPS in a large patient population with both
benign and malignant strictures as well as non-stricture etiologies. Our findings suggest
that anchoring of FCSEMS with a 7-Fr or 10-Fr DPS does not decrease the risk of stent
migration. Only benign biliary stricture and previous sphincterotomy were to have a
significant association with stent migrations (P = 0.01). We did not find evidence to
support the routine placement of anchoring DPS.
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INTRODUCTION
Fully covered self-expandable metal stents (FCSEMSs) have been widely used as an
effective biliary endoprosthesis in the setting of pancreaticobiliary conditions such as
benign and malignant strictures, post-sphincterotomy bleeding, and occasionally bile
leaks[1]. The primary advantages of covered stents are a lower rate of tumor ingrowth,
longer patency, and their potential removability compared to uncovered stents.
However, one concern about FCSEMSs is a higher migration rate than uncovered
stents[2]. The migration rate of FCSEMSs in prospective studies for benign biliary
strictures is 5%-37%[1]. In this study, we conducted a retrospective analysis to evaluate
the efficacy of 7-French (Fr) and 10-Fr double-pigtail plastic stent (DPS) within the
FCSEMS as an anti-migration technique. We compared the rate of stent migration
between patients who received FCSEMS alone and those who received both an
FCSEMS and anchoring DPS in a large patient population with both benign and
malignant strictures as well as non-stricture etiologies.
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MATERIALS AND METHODS
Between July 2015 and April 2017, 1366 patients had undergone endoscopic
retrograde cholangiopancreatography (ERCP) at our institution. Among these, 203
patients with FCSEMS placement with or without DPS were identified. The review
and analysis were conducted through our endoscopy reporting system (ProVation®
MD) and medical records. Patients included in the study had FCSEMS insertion for
the treatment of malignant biliary stricture, benign biliary stricture, and non-stricture
etiology such as post-sphincterotomy bleeding and bile leak.
After the Institutional Review Board and the Ethics Committee of our hospital
approved the study protocol, data was extracted by reviewing patient charts, ERCP
reports, and fluoroscopic images. Patients who only had uncovered stents or plastic
stents placed were excluded. All endoscopic procedures were performed by three
advanced endoscopists. Comprehensive data were collected through Microsoft Excel
spreadsheet and included the following: stent type [WallflexTM (Boston Scientific) vs
Viabil® (Gore Medical)], the diameter of double-pigtail PS (7-Fr vs 10-Fr), indications
for FCSEMS placement including stricture type (malignant vs benign), and nonstricture etiologies such as post-sphincterotomy bleeding and bile leak.
Baseline patient characteristics were identified, such as previous cholecystectomy,
biliary sphincterotomy, history of stent migration, choledocholithiasis, and diameter
of the common bile duct (CBD). After stent placement and during the follow-up
period, patients’ records were reviewed to verify the stent position. We defined
FCSEMS migration endoscopically if the stent was no longer visible through the major
papilla. It either migrates proximally (into the bile duct) or distally (out of the bile of
duct). The anti-migration properties of FCSEMSs include higher radial force,
anchoring flap, anchoring fins and flared ends have been designed to prevent the
migration. Categorical data were analyzed using the Chi-Square test and Fisher Exact
test and continuous data using non-parametric tests. A regression analysis was
performed to identify factors independently associated with increased risk of stent
migration. All analyses were completed in SAS 9.4 (SAS Institute Inc., Cary, NC,
United States).
The primary endpoint of the study was to compare stent migration rates between
patients who received FCSEMSs alone and those who received both an FCSEMS with
an anchoring DPS. A secondary endpoint was the presence of complications related to
stent migration.

RESULTS
1366 patients had undergone ERCP by three advanced endoscopists over 21-mo
period; among these, 203 patients had FCSEMS placed with or without DPS (88
females and 115 males). 65 patients had FCSEMSs with DPS, and 138 had FCSEMSs
alone (Table 1 and Table 2). 95 patients had a malignant stricture, 82 patients had a
benign stricture, 12 patients had bile leak, 12 patients had cholangitis, and nine
patients had post-sphincterotomy bleeding (Figure 1). For the patients with stent
migration, 12 (66.7%) had a benign biliary stricture, and 6 (33.3%) did not have, while
for the patients without stent migration, 70 (37.8%) had a benign biliary stricture and
115 (62.2%) did not have (P = 0.01). Also. For patients with stent migration, 12 (66.7%)
had the previous sphincterotomy, and 6 (33.3%) did not have, while for the patients
without stent migration, 71 (38.4%) had the previous sphincterotomy and 114 (61.6%)
did not have (P = 0.01). The migration rate in patients with benign biliary stricture
was 14.6% and for those with non-benign biliary stricture was 5%. Migration rate in
patients with the previous sphincterotomy was 14.5%, and those without previous
sphincterotomy was 5%. Therefore, the distribution of patients that had a benign
biliary stricture and previous sphincterotomy were significantly different between
patients with stent migration and patients with no stent migration. There was no
significant association between any of the other tested variables including anchoring
the FCSEMSs with DPS and the risk of stent migration. The migration rate in patients
with anchored FCSEMSs with DPS was 6%, and those without anchoring DPS was
10% (P = 0.35). Overall, migration was reported in 18 patients with FCSEMS
placement out of 203 patients with an overall migration rate of 9.7%.

DISCUSSION
FCSEMS has been associated with longer patency than uncovered stents in some
studies even though they may have higher rates of migration[3-5]. To minimize the risk
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Table 1 Clinical characteristics of patients who underwent fully covered self-expanding metal stent placement with or without doublepigtail plastic stent
Characteristic

Determinant

Gender

Race

Age

Frequency count

Percent of total frequency

Female

88

43.34

Male

115

56.65

Black

9

4.43

White

194

95.56

Mean (62.97); Range (23.00-91.00)

Brand of FCSEMS

Viabil fully covered

90

44.33

Viabil fully covered with proximal fenestration

63

31.03

WallFlex

50

24.63
94.08

Cholangitis drainage

Choledocholithiasis at time of stent placement

History of cholecystectomy

History of stent migration

Length of FCSEMS (cm)

No

191

Yes

12

5.91

No

188

92.61

Yes

15

7.38

No

92

45.32

Yes

111

54.67

No

196

96.55

Yes

7

3.44

4

30

14.77

6

106

52.21

8

47

23.15

10

20

9.85

Length of Stricture (mm)

Mean (19.21); Range (0.00-90.00)

CBD diameter (mm)

Mean (11.19); Range (3.00-35.00)

Malignant stricture

Migration

Post sphincterotomy bleed

Previous sphincterotomy

Sphincterotomy at time of stent deployment

No

108

53.20

Yes

95

46.79

No

185

91.13

Yes

18

8.86
95.56

No

194

Yes

9

4.43

No

120

59.11

Yes

83

40.88

No

82

40.39

Yes

121

59.60

FCSEMS: Fully covered self-expanding metal stent; DPS: Double-pigtail plastic stent.

of migration, FCSEMSs have been designed with anti-migration mechanical
properties, such as higher radial force, an anchoring flap, and specific stent flare
structures[6-8]. Nevertheless, other modifications such as anchoring fins and flared ends
have been designed to prevent the migration of FCSEMSs, even though; there are no
randomized studies to evaluate their effectiveness[7,9].
In our study, the risk of migration of biliary FCSEMS seemed to be lower than
previous studies at 9.7%. In contrast, migration rates have been reported to be up to
37.5% in the previous study[1]. To our knowledge, there are only two studies that have
evaluated the efficacy of anchoring DPS to prevent migration of FCSEMS.
In a randomized controlled study, Park et al[10] described their experience of placing
a 5-Fr DPS into FCSEMS in 17 patients out of 33 patients who received FCSEMS for
benign biliary strictures. During the follow-up, the migration rate was significantly
lower in the anchored group (FCSEMS + anchoring DPS) compared with a nonanchored group (FCSEMS alone): 1/16 (6.3%) vs 7/17 (41.2%) respectively, P = 0.024.
However, in the study by Park et al[10], their sample size was underpowered to identify
any significant clinical difference between the two groups and the study was
terminated before the planned sample size was reached.
Recently, Katsinelos et al[11] investigated the efficacy of using a 10-Fr DPS to prevent
migration in 10 patients with malignant biliary strictures and one patient with a
suprapapillary benign biliary stenosis. These patients were prospectively enrolled.
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Figure 1

Figure 1 Indication for fully covered self-expandable metal stent with or without double-pigtail plastic stent
placement.

The median follow-up period was eight months, and no migration of FCSEMS was
reported. Even though it was the first study to assess the use of anchoring a 10-Fr DPS
inside an FCSEMS as anti-migration technique, it was limited by small sample size
and lack of randomization.
Our study contains a much larger sample size than the studies described above.
Also, we included patients with a variety of indications for FCSEMS placement, such
as benign and malignant biliary stricture, post sphincterotomy bleed, cholangitis
drainage, and bile leak. Our study was different from the above studies because 90%
of DPS were 7-Fr and 10% were 10-Fr.
The complication rate from stent migration was very low in our study. Five patients
developed obstructive jaundice due to stent migration, and only one patient
developed stent-induced cholecystitis secondary to the occlusion of the cystic orifice
by a proximally migrated stent in a patient with pancreatic cancer. Acute cholecystitis
after placement of a biliary metallic stent has been reported in up to 13% and is likely
associated with tumor involvement at the orifice of the cystic duct[12-14].
This study was limited by being retrospective and not being randomized. However,
this is the first study to investigate the efficacy of a 7-Fr DPS inside an FCSEMS as an
anti-migration technique and the first study to assess the migration rate of FCSEMS
with or without anchoring DPS among those with non-stricture etiologies such postsphincterotomy bleeding and bile leak.
In conclusion, our findings suggest that anchoring of FCSEMS with a 7-Fr or 10-Fr
DPS does not decrease the risk of stent migration. Only benign biliary stricture and
previous Sphincterotomy were to have a significant association with stent migrations
(P = 0.01). We did not find evidence to support the routine placement of anchoring
DPS. However, prospective randomized controlled studies are needed to evaluate the
efficacy of an anchoring DPS within an FCSEMS as an anti-migration technique.
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Table 2 Comparison between patients who had migration of fully covered self-expanding metal stent placement (FCSEMS) and patient
who had no migration of FCSEMS
Characteristic

Determinant

Gender

Age
Race

Post sphincterotomy bleed

Bile leak

Benign biliary stricture

Cholangitis drainage

Migration (n = 18)

No migration (n = 185)

P-value
0.1626

Female

5 (27.8%)

83 (44.9%)

Male

13 (72.2%)

102 (55.1%)

-

mean ± SD (range)

59.83 (12.38) - (34.00, 91.00)

63.28 (15.23) - (23.00, 91.00)

0.3539
0.1494

Black

2 (11.1%)

7 (3.8%)

White

16 (88.9%)

178 (96.2%)

-

No

17 (94.4%)

177 (95.7%)

0.8086

Yes

1 (5.6%)

8 (4.3%)

0.1418

No

18 (100.0%)

165 (89.2%)

Yes

0 (0.0%)

20 (10.8%)

-

No

6 (33.3%)

115 (62.2%)

0.0173

Yes

12 (66.7%)

70 (37.8%)

-

No

18 (100.0%)

173 (93.5%)

0.2653

Yes

0 (0.0%)

12 (6.5%)

-

Malignant stricture

No

13 (72.2%)

95 (51.4%)

0.0902

Yes

5 (27.8%)

90 (48.6%)

-

Brand of FCSEMS

Viabil fully covered

8 (44.4%)

82 (44.3%)

0.2294

Viabil fully covered with
proximal fenestration

3 (16.7%)

60 (32.4%)

-

WallFlex

7 (38.9%)

43 (23.2%)

-

4

2 (11.1%)

28 (15.1%)

0.9376

6

9 (50.0%)

97 (52.4%)

-

Length of FCSEMS (cm)

8

5 (27.8%)

42 (22.7%)

10

2 (11.1%)

18 (9.7%)

-

No

14 (77.8%)

124 (67.0%)

0.3507

Yes

4 (22.2%)

61 (33.0%)

-

Length of stricture (mm)

mean ± SD (range)

14.67 (10.72) - (0.00, 40.00)

19.65 (19.32) - (0.00, 90.00)

0.0958

CBD diameter (mm)

mean ± SD (range)

11.61 (4.50) - (5.00,22.00)

11.15 (4.70) - (3.00,35.00)

0.6878

No

5 (27.8%)

87 (47.0%)

0.1173

Yes

13 (72.2%)

98 (53.0%)

-

No

6 (33.3%)

114 (61.6%)

0.0198

Yes

12 (66.7%)

71 (38.4%)

-

No

9 (50.0%)

73 (39.5%)

0.3843

Yes

9 (50.0%)

112 (60.5%)

-

No

17 (94.4%)

179 (96.8%)

0.6078

Anchored FCSEMSs with
DPS

History of cholecystectomy

Previous sphincterotomy

Sphincterotomy at time of
stent deployment
History of stent migration

Choledocholithiasis at time
of stent placement

Yes

1 (5.6%)

6 (3.2%)

-

No

16 (88.9%)

172 (93.0%)

0.5272

Yes

2 (11.1%)

13 (7.0%)

-

FCSEMS: Fully covered self-expanding metal stent; DPS: Double-pigtail plastic stent.

ARTICLE HIGHLIGHTS
Research background
Fully covered self-expandable metal stents (FCSEMSs) have been widely used as an effective
biliary endoprosthesis in the setting of pancreaticobiliary conditions such as benign and
malignant strictures, post-sphincterotomy bleeding, and occasionally bile leaks. The primary
advantages of covered stents are a lower rate of tumor ingrowth, longer patency, and their
potential removability compared to uncovered stents. However, one concern about FCSEMSs is a
higher migration rate than uncovered stents. In this study, we conducted a retrospective analysis
to evaluate the efficacy of 7-French (Fr) and 10-Fr double-pigtail plastic stent (DPS) within the
FCSEMS as an anti-migration technique. We compared the rate of stent migration between
patients who received FCSEMS alone and those who received both an FCSEMS and anchoring
DPS in a large patient population with both benign and malignant strictures as well as nonstricture etiologies. We did not find evidence to support the routine placement of anchoring DPS.
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We found that anchoring of FCSEMS with a 7-Fr or 10-Fr DPS does not decrease the risk of stent
migration.

Research motivation
FCSEMSs have been commonly used as an effective biliary endoprosthesis in the setting of
pancreaticobiliary conditions such as benign and malignant strictures. To minimize the risk of
migration, FCSEMSs have been designed with different anti-migration mechanical properties.
The use of DPS is still unclear as an anti-migration method. Prospective randomized controlled
studies are needed to evaluate the efficacy of an anchoring DPS within an FCSEMS as an antimigration technique.

Research objectives
The main objective of the study was to assess to the rate of stent migration between patients who
received FCSEMS alone and those who received both an FCSEMS and anchoring DPS in both
benign and malignant strictures as well as non-stricture etiologies. To our knowledge, there are
only two small retrospective studies that have evaluated the efficacy of anchoring DPS to
prevent migration of FCSEMS. So, more randomized controlled trials with a larger number of
patients are needed.

Research methods
A retrospective analysis of endoscopy reporting system and medical records of patients who
underwent ERCP with FCSEMS placement was conducted. The review and analysis were
conducted through our endoscopy reporting system (ProVation® MD) and medical records.
Patients included in the study had FCSEMS insertion for the treatment of malignant biliary
stricture, benign biliary stricture, and non-stricture etiology such as post-sphincterotomy
bleeding and bile leak. Data included stent type [WallflexTM (Boston Scientific) vs Viabil® (Gore
Medical)], the diameter of double-pigtail PS (7-Fr vs 10-Fr), and indications for FCSEMS
placement. We defined FCSEMS migration endoscopically if the stent was no longer visible
through the major papilla. It either migrates proximally (into the bile duct) or distally (out of the
bile of duct).

Research results
There was no significant association between any of the other tested variables including
anchoring the FCSEMSs with DPS and the risk of stent migration. The migration rate in patients
with anchored FCSEMSs with DPS was 6%, and those without anchoring DPS was 10% (P =
0.35). Overall, migration was reported in 18 patients with FCSEMS placement out of 203 patients
with an overall migration rate of 9.7%. The distribution of patients that had a benign biliary
stricture and previous sphincterotomy were significantly different between patients with stent
migration and patients with no stent migration.

Research conclusions
In our study, the risk of migration of biliary FCSEMS was 9.7 %. Anchoring an FCSEMS with a 7Fr or 10-Fr DPS does not decrease the risk of stent migration. Routine placement of anchoring
stents is unnecessary. We believe that further randomized controlled trials with a larger number
of patients might be helpful to ascertain if anchoring an FCSEMS with DPS is useful as an antimigration technique.

Research perspectives
Anchoring of FCSEMS with a 7-Fr or 10-Fr DPS does not decrease the risk of stent migration.
Only benign biliary stricture and previous Sphincterotomy were to have a significant association
with stent migrations. Needs more prospective large studies. More randomized controlled trials
with a larger number of patients are needed.

REFERENCES
1

2

3

4

5

WJGE

Dumonceau JM, Tringali A, Blero D, Devière J, Laugiers R, Heresbach D, Costamagna G; European
Society of Gastrointestinal Endoscopy. Biliary stenting: indications, choice of stents and results: European
Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 2012; 44: 277-298 [PMID:
22297801 DOI: 10.1055/s-0031-1291633]
Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, Nakai Y, Yamamoto N, Tada M,
Yoshida H, Shiratori Y, Kawabe T, Omata M. A prospective randomised study of "covered" versus
"uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004; 53:
729-734 [PMID: 15082593 DOI: 10.1136/gut.2003.018945]
Lee JH, Krishna SG, Singh A, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA.
Comparison of the utility of covered metal stents versus uncovered metal stents in the management of
malignant biliary strictures in 749 patients. Gastrointest Endosc 2013; 78: 312-324 [PMID: 23591331
DOI: 10.1016/j.gie.2013.02.032]
Kitano M, Yamashita Y, Tanaka K, Konishi H, Yazumi S, Nakai Y, Nishiyama O, Uehara H, Mitoro A,
Sanuki T, Takaoka M, Koshitani T, Arisaka Y, Shiba M, Hoki N, Sato H, Sasaki Y, Sato M, Hasegawa K,
Kawabata H, Okabe Y, Mukai H. Covered self-expandable metal stents with an anti-migration system
improve patency duration without increased complications compared with uncovered stents for distal
biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol
2013; 108: 1713-1722 [PMID: 24042190 DOI: 10.1038/ajg.2013.305]
Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency

https://www.wjgnet.com

371

May 16, 2019

Volume 11

Issue 5

Emhmed Ali S et al. Should FCSEMS be anchored with DPS?

6

7

8

9

10

11

12

13

14

WJGE

of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct
obstruction. Gastrointest Endosc 2011; 74: 321-327.e1-3 [PMID: 21683354 DOI:
10.1016/j.gie.2011.03.1249]
Isayama H, Nakai Y, Toyokawa Y, Togawa O, Gon C, Ito Y, Yashima Y, Yagioka H, Kogure H, Sasaki
T, Arizumi T, Matsubara S, Yamamoto N, Sasahira N, Hirano K, Tsujino T, Toda N, Tada M, Kawabe T,
Omata M. Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest
Endosc 2009; 70: 37-44 [PMID: 19249766 DOI: 10.1016/j.gie.2008.09.032]
Park DH, Lee SS, Lee TH, Ryu CH, Kim HJ, Seo DW, Park SH, Lee SK, Kim MH, Kim SJ. Anchoring
flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with
benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos). Gastrointest
Endosc 2011; 73: 64-70 [PMID: 21184871 DOI: 10.1016/j.gie.2010.09.039]
Isayama H, Kawakubo K, Nakai Y, Inoue K, Gon C, Matsubara S, Kogure H, Ito Y, Tsujino T, Mizuno S,
Hamada T, Uchino R, Miyabayashi K, Yamamoto K, Sasaki T, Yamamoto N, Hirano K, Sasahira N, Tada
M, Koike K. A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable
distal malignant biliary obstruction: a multicenter feasibility study. Gut Liver 2013; 7: 725-730 [PMID:
24312715 DOI: 10.5009/gnl.2013.7.6.725]
Moon SH, Kim MH, Park DH, Song TJ, Eum J, Lee SS, Seo DW, Lee SK. Modified fully covered selfexpandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced
chronic pancreatitis, with a focus on the safety profile and reducing migration. Gastrointest Endosc 2010;
72: 86-91 [PMID: 20493483 DOI: 10.1016/j.gie.2010.01.063]
Park JK, Moon JH, Choi HJ, Min SK, Lee TH, Cheon GJ, Cheon YK, Cho YD, Park SH, Kim SJ.
Anchoring of a fully covered self-expandable metal stent with a 5F double-pigtail plastic stent to prevent
migration in the management of benign biliary strictures. Am J Gastroenterol 2011; 106: 1761-1765
[PMID: 21788992 DOI: 10.1038/ajg.2011.212]
Katsinelos P, Lazaraki G, Gkagkalis S, Chatzimavroudis G, Anastasiadou K, Georgakis N, Giouleme O,
Zavos C, Kountouras J. A fully covered self-expandable metal stent anchored by a 10-Fr double pigtail
plastic stent: an effective anti-migration technique. Ann Gastroenterol 2017; 30: 114-117 [PMID:
28042247 DOI: 10.20524/aog.2016.0089]
Kahaleh M, Tokar J, Conaway MR, Brock A, Le T, Adams RB, Yeaton P. Efficacy and complications of
covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 2005; 61: 528-533 [PMID:
15812404 DOI: 10.1016/j.gie.2011.01.043]
Isayama H, Kawabe T, Nakai Y, Tsujino T, Sasahira N, Yamamoto N, Arizumi T, Togawa O, Matsubara
S, Ito Y, Sasaki T, Hirano K, Toda N, Komatsu Y, Tada M, Yoshida H, Omata M. Cholecystitis after
metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol
2006; 4: 1148-1153 [PMID: 16904950 DOI: 10.1016/j.cgh.2006.06.004]
Suk KT, Kim HS, Kim JW, Baik SK, Kwon SO, Kim HG, Lee DH, Yoo BM, Kim JH, Moon YS, Lee
DK. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest
Endosc 2006; 64: 522-529 [PMID: 16996343 DOI: 10.1016/j.gie.2006.06.022]

https://www.wjgnet.com

372

May 16, 2019

Volume 11

Issue 5

Published By Baishideng Publishing Group Inc
7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Telephone: +1-925-2238242
Fax: +1-925-2238243
E-mail: bpgoffice@wjgnet.com
Help Desk: https://www.f6publishing.com/helpdesk
https://www.wjgnet.com

© 2019 Baishideng Publishing Group Inc. All rights reserved.

